Insights to Clinical Use of Serial Determination in Titers of Cyclic Citrullinated Peptide Autoantibodies
Anti-cyclic citrullinated peptide (CCP) antibody is a useful marker for the diagnosis and prognosis of rheumatoid arthritis (RA). Recently, clinical significance of follow-up in anti-CCP antibody titer has been pointed out. Thus, we investigated the serial determination in anti-CCP antibodies titer...
Saved in:
Main Authors: | Toshiaki Kogure (Author), Takeshi Tatsumi (Author), Hiroshi Fujinaga (Author), Atsushi Niizawa (Author), Katsutoshi Terasawa (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2007-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
No Correlation Exists between Disease Activity and the Expression of Killer-Cell Immunoglobulin-Like Receptors in Patients with Rheumatoid Arthritis
by: Toshiaki Kogure, et al.
Published: (2007) -
Killer-Cell Inhibitory Receptors, CD158a/b, are Upregulated by Interleukin-2, but not Interferon-γ or Interleukin-4
by: Toshiaki Kogure, et al.
Published: (1999) -
Features of Clinical and Laboratory Parameters in Children with Arthritis, which Have Increased Antibody Titers to Cyclic Citrullinated Peptide and Modified Citrullinated Vimentin
by: I.S. Lebets, et al.
Published: (2013) -
Significance of anti-cyclic citrullinated peptide autoantibodies in immune-mediated inflammatory skin disorders with and without arthritis
by: Chander Grover, et al.
Published: (2016) -
Presence of anti-cyclic citrullinated peptide antibody isotypes in juvenile idiopathic arthritis synovial fluid indicates autoantibody production at the site of inflammation
by: Gilliam Brooke E, et al.
Published: (2012)